Literature DB >> 21221858

Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections.

Wengen Chen1, Qi Cao, Vasken Dilsizian.   

Abstract

Studies have repeatedly shown the utility of (123)I-mIBG cardiac sympathetic imaging for identifying symptomatic heart failure patients most likely to experience adverse cardiac events. Delayed heart-to-mediastinal ratio (H/M) and washout rate derived from meta-iodobenzylguanidine (mIBG) scintigraphy have been used to monitor response to medical treatment. However, there is great variation of H/M ratio among publications from various institutions. The current article systemically reviews factors that can potentially affect H/M ratio, particularly the acquisition parameters, and proposes new approaches and/or procedures to standardize the imaging procedure and minimize the variation of H/M among institutions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221858     DOI: 10.1007/s11886-010-0157-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  25 in total

1.  Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.

Authors:  Myron C Gerson; Laura L Craft; Nancy McGuire; Damodhar P Suresh; William T Abraham; Lynne E Wagoner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  Introduction of new tests: low are the mountains, high the expectations.

Authors:  Vasken Dilsizian; Y Chandrashekhar; Jagat Narula
Journal:  JACC Cardiovasc Imaging       Date:  2010-01

3.  Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study.

Authors:  H Ogita; T Shimonagata; M Fukunami; K Kumagai; T Yamada; Y Asano; A Hirata; M Asai; H Kusuoka; M Hori; N Hoki
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 4.  Cardiac sympathetic imaging with mIBG in heart failure.

Authors:  Ignasi Carrió; Martin R Cowie; Junichi Yamazaki; James Udelson; Paolo G Camici
Journal:  JACC Cardiovasc Imaging       Date:  2010-01

5.  Effect of specific activity on cardiac uptake of iodine-123-MIBG.

Authors:  J Farahati; D Bier; M Scheubeck; M Lassmann; L F Schelper; I Grelle; H Hanscheid; J Biko; K H Graefe; C Reiners
Journal:  J Nucl Med       Date:  1997-03       Impact factor: 10.057

6.  Myocardial imaging with a radioiodinated norepinephrine storage analog.

Authors:  D M Wieland; L E Brown; W L Rogers; K C Worthington; J L Wu; N H Clinthorne; C A Otto; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-01       Impact factor: 10.057

7.  Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake.

Authors:  Yusuke Inoue; Akira Suzuki; Ichiro Shirouzu; Toru Machida; Yasunori Yoshizawa; Fumihide Akita; Satoshi Ohnishi; Kohki Yoshikawa; Kuni Ohtomo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

8.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.

Authors:  E B Henderson; J K Kahn; J R Corbett; D E Jansen; J J Pippin; P Kulkarni; V Ugolini; M S Akers; C Hansen; L M Buja
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

9.  Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart.

Authors:  M Nakajo; K Shimabukuro; H Yoshimura; R Yonekura; Y Nakabeppu; P Tanoue; S Shinohara
Journal:  J Nucl Med       Date:  1986-01       Impact factor: 10.057

10.  Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.

Authors:  Hein J Verberne; Jan B A Habraken; Berthe L F van Eck-Smit; Denis Agostini; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-06       Impact factor: 9.236

View more
  10 in total

Review 1.  SPECT and PET in ischemic heart failure.

Authors:  George Angelidis; Gregory Giamouzis; Georgios Karagiannis; Javed Butler; Ioannis Tsougos; Varvara Valotassiou; George Giannakoulas; Nikolaos Dimakopoulos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis; Panagiotis Georgoulias
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

2.  Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation as assessed by 123I-mIBG scintigraphy in patients with heart failure with reduced ejection fraction submitted to cardiac resynchronization therapy : Assessment of cardiac autonomic denervation by GLS in patients with heart failure with reduced ejection fraction submitted to CRT.

Authors:  Madalena Coutinho Cruz; Ana Abreu; Guilherme Portugal; Helena Santa-Clara; Pedro S Cunha; Mario M Oliveira; Vanessa Santos; Luís Oliveira; Pedro Rio; Inês Rodrigues; Luís A Morais; Rui C Ferreira; Miguel M Carmo
Journal:  J Nucl Cardiol       Date:  2017-12-05       Impact factor: 5.952

3.  Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods.

Authors:  Omar Asghar; Parthiban Arumugam; Ian Armstrong; Simon Ray; Matthias Schmitt; Rayaz A Malik
Journal:  Nucl Med Commun       Date:  2017-01       Impact factor: 1.690

4.  123I-mIBG: Simplicity and reproducibility.

Authors:  Kevin Curl; Christopher L Hansen
Journal:  J Nucl Cardiol       Date:  2018-01-29       Impact factor: 5.952

Review 5.  Molecular imaging of amyloidosis: will the heart be the next target after the brain?

Authors:  Wengen Chen; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

6.  Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients.

Authors:  Ben F Bulten; Hein J Verberne; Louise Bellersen; Wim J G Oyen; Aida Sabaté-Llobera; Annelies M C Mavinkurve-Groothuis; Livia Kapusta; Hanneke W M van Laarhoven; Lioe-Fee de Geus-Oei
Journal:  Cancer Chemother Pharmacol       Date:  2015-09-23       Impact factor: 3.333

Review 7.  Standardization of 123I-meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications.

Authors:  Kenichi Nakajima; Derk O Verschure; Koichi Okuda; Hein J Verberne
Journal:  Clin Transl Imaging       Date:  2017-05-04

Review 8.  The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathy.

Authors:  Thomas Klein; Vasken Dilsizian; Qi Cao; Wengen Chen; Timm-Michael Dickfeld
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

9.  Interobserver variability of heart-to-mediastinum ratio in I-123 MIBG sympathetic imaging.

Authors:  Ben F Bulten; Roel L F van der Palen; Hanneke W M van Laarhoven; Livia Kapusta; Annelies M C Mavinkurve-Groothuis; Lioe-Fee de Geus-Oei
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

10.  Cardiac I123-MIBG correlates better than ejection fraction with symptoms severity in systolic heart failure.

Authors:  Sandra M Miranda; Samuel D Moscavitch; Larissa R Carestiato; Renata M Felix; Ronaldo C Rodrigues; Leandro R Messias; Jader C Azevedo; Antonio Cláudio L Nóbrega; Evandro Tinoco Mesquita; Claudio Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2013-07       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.